Satoshi Fujii

9PUBLICATIONS
148CO-AUTHORS
Predictive and prognostic markersSolid tumoursMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 17, 2026
Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancer.

|Apr 25, 2026
Establishment of Salivary Gland Tumors Arising in Salivary Gland-Specific EWSR1::ATF1 Transgenic Mice.

|Dec 22, 2025
Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of ALK Fusion Gene-Associated Renal Tumorigenesis.

Go Noguchi, Masaya Baba, Shinji Ohtake

|Aug 23, 2025
Validation of the 2023 FIGO staging system and its concordance with the JSGO guidelines in endometrial cancer: A multi-institutional retrospective study in Japan.

Takatoshi Manabe, Hiroko Machida, Taichi Mizushima

|Feb 01, 2025
Clinicopathological Significance of Extranodal Extension in Hypopharyngeal and Laryngeal Squamous Cell Carcinoma.

Natsumi Kijima, Yui Uzawa, Yuri Hirai

|Aug 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer.

Naoko Iida, Mitsuho Imai, Wataru Okamoto

Pageof 2

Frequent Collaborators

2 joint publications

Ryosuke Jikuya

2 joint publications

Yoshito Komatsu

2 joint publications

Toshiki Masuishi

2 joint publications

Yoshiaki Nakamura